Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium.

Alonso A, Krijthe BP, Aspelund T, Stepas KA, Pencina MJ, Moser CB, Sinner MF, Sotoodehnia N, Fontes JD, Janssens AC, Kronmal RA, Magnani JW, Witteman JC, Chamberlain AM, Lubitz SA, Schnabel RB, Agarwal SK, McManus DD, Ellinor PT, Larson MG, Burke GL, Launer LJ, Hofman A, Levy D, Gottdiener JS, Kääb S, Couper D, Harris TB, Soliman EZ, Stricker BH, Gudnason V, Heckbert SR, Benjamin EJ. · 2013

Read Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. by Alonso A, Krijthe BP, Aspelund T, Stepas KA, Pencina MJ, Moser CB, Sinner MF, Sotoodehnia N, Fontes JD, Janssens AC, Kronmal RA, Magnani JW, Witteman JC, Chamberlain AM, Lubitz SA, Schnabel RB, Agarwal SK, McManus DD, Ellinor PT, Larson MG, Burke GL, Launer LJ, Hofman A, Levy D, Gottdiener JS, Kääb S, Couper D, Harris TB, Soliman EZ, Stricker BH, Gudnason V, Heckbert SR, Benjamin EJ. (2013) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3647274.txt.

Introduction

Who will develop a racing, uneven heartbeat years from now is the target of a risk model by Alonso and a large consortium team. Their study ran in a 2013 Journal of the American Heart Association. The condition, atrial fibrillation, is common in later life and raises stroke risk. A simple score from facts a family doctor already holds could flag high-risk patients and set a bar for testing new risk factors.

The team pooled 18,556 men and women aged 46 to 94 from three United States cohorts, among them 1,186 new cases of the condition. Their five-year model uses age, race, height, weight, blood pressure, smoking, blood pressure drugs, diabetes and past heart attack or heart failure. It sorted risk well at home and fairly in two European checks. Heart trace data added nothing.

Catalog record

CREATORAlonso A, Krijthe BP, Aspelund T, Stepas KA, Pencina MJ, Moser CB, Sinner MF, Sotoodehnia N, Fontes JD, Janssens AC, Kronmal RA, Magnani JW, Witteman JC, Chamberlain AM, Lubitz SA, Schnabel RB, Agarwal SK, McManus DD, Ellinor PT, Larson MG, Burke GL, Launer LJ, Hofman A, Levy D, Gottdiener JS, Kääb S, Couper D, Harris TB, Soliman EZ, Stricker BH, Gudnason V, Heckbert SR, Benjamin EJ.
YEAR2013
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3647274

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Simple Risk Model Predicts Incidence of Atrial Fibrillation in a Racially and Geographically Diverse Population: the CHARGE‐AF Consortium By Alvaro Alonso, Bouwe P Krijthe, Thor Aspelund, Katherine A Stepas, Michael J Pencina, Carlee B Moser, Moritz F Sinner, Nona Sotoodehnia, João D Fontes, A Cecile J W Janssens, Richard A Kronmal, Jared W Magnani Published in: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease DOI: 10.1161/JAHA.112.000102 ABSTRACT Abstract Background Tools for the prediction of atrial fibrillation (AF) may identify high‐risk individuals more likely to benefit from preventive interventions and serve as a benchmark to test novel putative risk factors. Methods and Results Individual‐level data from 3 large cohorts in the United States (Atherosclerosis Risk in Communities [ARIC] study, the Cardiovascular Health Study [CHS], and the Framingham Heart Study [FHS]), including 18 556 men and women aged 46 to 94 years (19% African Americans, 81% whites) were pooled to derive predictive models for AF using clinical variables. Validation of the derived models was performed in 7672 participants from the Age, Gene and Environment—Reykjavik study (AGES) and the Rotterdam Study (RS). The analysis included 1186 incident AF cases in the derivation cohorts and 585 in the validation cohorts. A simple 5‐year predictive model including the variables age, race, height, weight, systolic and diastolic blood pressure, current smoking, use of antihypertensive medication, diabetes, and history of myocardial infarction and heart failure had good discrimination (C‐statistic, 0.765; 95% CI, 0.748 to 0.781). Addition of variables from the electrocardiogram did not improve the overall model discrimination (C‐statistic, 0.767; 95% CI, 0.750 to 0.783; categorical net reclassification improvement, −0.0032; 95% CI, −0.0178 to 0.0113). In the validation cohorts, discrimination was acceptable (AGES C‐statistic, 0.664; 95% CI, 0.632 to 0.697 and RS C‐statistic, 0.705; 95% CI, 0.664 to 0.747) and calibration was adequate. Conclusion A risk model including variables readily available in primary care settings adequately predicted AF in diverse populations from the United States and Europe. Keywords: atrial fibrillation, epidemiology, risk factors INTRODUCTION Atrial fibrillation (AF), a common cardiac arrhythmia, has emerged as a major public health problem as a result of wide prevalence,1 close relation to stroke and mortality,2 and associated costs.3 Tools for the prediction of AF could help identify high‐risk individuals and serve as a benchmark to test potential novel risk factors. To this end, the Framingham Heart Study (FHS) developed a risk score for AF, which included a number of variables easily obtained during routine clinical examination.4 This risk score was recently validated in 2 additional population‐based cohorts, the Age Gene/Environment Susceptibility‐Reykjavik (AGES) Study and the Cardiovascular Health Study (CHS), where it demonstrated reasonable performance.5 An alternative score has been developed in the Atherosclerosis Risk in Communities (ARIC) Study, with similar predictive capability.6 These studies included atrial flutter in their definition of AF. This inclusion is reasonable because, even though atrial flutter and AF are electrophysiologically distinct, most patients with atrial flutter have or will develop AF and the risk of stroke associated with atrial flutter is similar to that observed in AF.7–8 Previous risk models are limited as a result of being developed in single cohorts. Though the FHS risk score has predicted AF reasonably well in other populations,5–6 it is unknown whether a risk model developed in a more geographically or racially diverse population would better predict AF. Previously developed models also require information from a 12‐lead electrocardiogram, which might be unavailable in some primary care settings. Therefore, we developed and validated a new predictive score for AF (including atrial flutter) in 5 US and European cohorts participating in the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) AF consortium.9 METHODS Study Cohorts Participant‐specific data from 3 community‐based cohorts in the United States (ARIC, CHS, and FHS) were pooled to develop a risk score for predicting AF, and the validation of this score was performed in 2 additional cohorts in Europe (AGES and the Rotterdam Study [RS]). A brief description of each participating cohort is provided below. For each cohort the determination of which examination to select as baseline was based on the availability of potential predictors and adequate follow‐up for the development of AF. Participants were excluded from this analysis if they had AF at baseline, were younger than 46 or older than 94 years of age, had serum creatinine ≥2.0 mg/dL, identified themselves as other than white or African American (n=30 ARIC, n=32 CHS, and n=62 RS participants), or had missing values for any of the variables of interest. After applying exclusion criteria, the derivation cohort included 18 556 participants and the validation cohorts included a total of 7672 participants. The number of individuals excluded by cohort is provided in the Table S1. Institutional Review Boards at the participating institutions approved the individual studies and study participants provided written informed consent. Atherosclerosis Risk in Communities Study The ARIC study recruited 15 792 men and women, aged 45 to 64 years, from 4 communities in the United States (Forsyth County, NC; Washington County, MD; Jackson, MS; and suburbs of Minneapolis, MN) in 1987–1989.10 Participants were mostly white in the Minnesota and Washington County field centers, white and African American in Forsyth County, and exclusively African American in the Jackson field center. After study inception, participants had 3 follow‐up examinations, each ≈3 years apart. For the present analysis, we included individuals attending the last follow‐up examination (visit 4, conducted in 1996–1998, n=11 656), with this examination used as baseline in all models. Of these, 10 675 met inclusion criteria. Cardiovascular Health Study In 1989–1990, CHS recruited 5201 men and women 65 years or older from 4 communities (Forsyth County, NC; Washington County, MD; Sacramento County, CA; and Pittsburgh, PA). Because of the different age inclusion criteria there was no overlap in ARIC and CHS participants. In 1992–1993, 687 African Americans were recruited in 3 of the 4 communities to increase minority representation.11 CHS participants had annual follow‐up examinations through 1999 with ongoing surveillance for cardiovascular events from baseline through the present. The 1989–1990 examination was considered baseline for 3768 (≈65%) of the eligible CHS participants in this analysis, while 1992–1993 was the baseline examination for the rest (n=1275). Framingham Heart Study In 1971–1975, the FHS Offspring cohort recruited 5124 predominantly white men and women, offspring (and their spouses) from the Original FHS cohort with follow‐up examinations every 4 to 8 years.12 The current analysis included participants of the FHS Offspring cohort free of AF attending the 6th examination cycle (1995–1998, n=3113); 2838 met inclusion criteria and were included in the analysis. Age, Gene/Environment Susceptibility Reykjavik Study The original Reykjavik Study, conducted between 1967 and 1996, included ≈19 000 men and women living in the greater Reykjavik area, born between 1907 and 1935.13 Survivors of this study were invited to be part of AGES, which recruited 5764 men and women in 2002–2006. Of these, 5427 had a complete clinic exam, and 4469 met inclusion criteria and were considered for this analysis. Rotterdam Study The RS, a prospective population‐based study aimed to assess the determinants of chronic conditions in the elderly, examined 7983 men and women, aged 55 years and older, living in the Rotterdam suburb of Ommoord in 1989–1993.14 Since then, participants have been continuously followed and

Read the complete text